Eterna Therapeutics
ERNA
32 hedge funds and large institutions have $78.3M invested in Eterna Therapeutics in 2021 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 2 increasing their positions, reducing their positions, and 4 closing their positions.
14,007% more capital invested
Capital invested by funds: $555K → $78.3M (+$77.7M)
625% more first-time investments, than exits
New positions opened: 29 | Existing positions closed: 4
357% more funds holding
Funds holding: 7 → 32 (+25)
0% more ownership
Funds ownership: 0% → 0% (+0%)
57% less call options, than puts
Call options by funds: $3.96M | Put options by funds: $9.29M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$26.9M |
| 2 |
CPWM
Cypress Point Wealth Management
Dallas,
Texas
|
+$9.07M |
| 3 |
State Street
Boston,
Massachusetts
|
+$8.5M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$7.92M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$6.77M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$432K |
| 2 |
NSIM
North Star Investment Management
Chicago,
Illinois
|
-$144K |
| 3 |
Renaissance Technologies
New York
|
-$74K |
| 4 |
VF
Virtu Financial
New York
|
-$68K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$2K |
ERNA Hedge Fund Activity: Q2 2021 in Review
32 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Eterna Therapeutics (ERNA) for Q2 2021, worth a combined $78.3M — up 14,007% from $555K a quarter earlier.
Buyers outnumbered sellers: 29 funds opened new ERNA positions and 4 closed out — a net gain of 25 holders — while 2 added to existing stakes and 0 trimmed.
The largest buyer was BlackRock, opening a new position worth an estimated $26.9M. The largest seller was Citadel Advisors, exiting entirely with an estimated $432K sold.
- 32 institutional investors held Eterna Therapeutics (ERNA) as of Q2 2021, up from 7 in Q1 2021.
- Funds reported $78.3M of Eterna Therapeutics stock for Q2 2021, up 14,007% quarter-over-quarter.
- 29 funds opened new Eterna Therapeutics positions in Q2 2021 and 4 closed out, a net change of +25 holders.
- The largest Eterna Therapeutics buyer in Q2 2021 was BlackRock, an estimated $26.9M added.
- The largest Eterna Therapeutics seller in Q2 2021 was Citadel Advisors, an estimated $432K sold.
Based on aggregated 13F filings for Q2 2021.